| abstract |
A combination drug used for treating a proliferative disease is provided. The invention relates to (a) a B-Raf inhibitor of the formula: (b) an epidermal growth factor receptor (EGFR) inhibitor, and optionally (c) phosphatidyl, for simultaneous, separate or sequential administration. A combination drug comprising an inositol 3-kinase (PI3K) -α inhibitor. Use of such a combination in the treatment of a proliferative disease. [Selection diagram] None |